PACS Group grants 146,498 RSUs to president
Jergensen Joshua reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Jergensen Joshua reported acquisition or exercise transactions in this Form 4 filing.
PACS Group, Inc. reported that President & COO Joshua Jergensen received an award of 146,498 restricted stock units (RSUs) of Common Stock. After this grant, he holds 2,813,845 shares directly. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 146,498 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PACS Group (PACS) disclose about Joshua Jergensen in this Form 4?
PACS Group reported that President & COO Joshua Jergensen received 146,498 restricted stock units of Common Stock. These RSUs are part of his equity compensation and increase his direct holdings to 2,813,845 shares after the award.
How many PACS Group (PACS) RSUs were granted to the President & COO?
The filing shows an award of 146,498 restricted stock units to President & COO Joshua Jergensen. Each RSU represents the right to receive one share of PACS Group Common Stock upon vesting, according to the disclosed terms.
What is the vesting schedule for Joshua Jergensen’s PACS Group (PACS) RSUs?
The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026. Vesting is conditioned on Joshua Jergensen’s continued service with PACS Group through each applicable vesting date.
Does the PACS Group (PACS) Form 4 indicate a market purchase or sale?
No market purchase or sale is reported. The Form 4 reflects a grant or award acquisition of 146,498 restricted stock units to Joshua Jergensen as compensation, with no per-share purchase price and no disposition of existing shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.